Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Epalrestat- An Aldose Reductase Inhibitor


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 3,718

Availability: In stock

  • Product Description

India leads the world with largest number of diabetic subjects earning the dubious distinction of being termed the “diabetes capital of the world”. Diabetic peripheral neuropathy developed in the majority of poorly controlled, diabetic patients as a late complication of diabetes. It is therefore of paramount importance to treat diabetic neuropathies appropriately as 50-60% of diabetic populations may progress to suffer from serious life threatening complications. Epalrestat is currently the only Aldose Reductase Inhibitor approved to treat subjective and objective symptoms of Diabetic Neuropathy. This book,provides how, Epalrestat 150 mg SR treatment showed clinically and statistically significant improvements in MNDS Score,Pressure threshold,and symptoms of peripheral neuropathy such as spontaneous pain,numbness in upper and lower limbs when compared with Epalrestat 50 mg IR tablet. The analysis should helps all the Medical Professionals Specially diabetologist and all diabetic patients whose need is to either prevent or treat neuropathy, a condition with pain filled life.

Product Specifications
SKU :COC84409
AuthorSachin Shende,Shiraz Mirza Baig and S.M. Doifode
Number of Pages120
Publishing Year2013-04-29T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08 00:00:00